Page last updated: 2024-10-24

verapamil and Orphan Diseases

verapamil has been researched along with Orphan Diseases in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Orphan Diseases: Rare diseases that have not been well studied.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waƛniewski, M1
Ochotny, R1
Klotzka, A1
StraburzyƄska-Migaj, E1
Grajek, S1

Other Studies

1 other study available for verapamil and Orphan Diseases

ArticleYear
[Fascicular tachycardia - a rare case of ventricular tachycardia].
    Kardiologia polska, 2010, Volume: 68, Issue:5

    Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Rare Diseases;

2010